J.P. Morgan Reiterates Overweight Rating On Dendreon

According J.P. Morgan, Dendreon DNDN Overweight rating is reiterated. J.P. Morgan said that it reiterates its OW rating on DNDN ahead of important near-term developments. “For the second time this year, the company is approaching a clustering of events that could have significant implications for the intermediate- and long-term future of Provenge.” Dendreon closed yesterday at $39.73.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsBiotechnologyDendreonHealth CareJ.P. Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!